Position in ARDX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$13,998,592
+$1,121,915 QoQ
Shares Held
2,336,994
+5.8% QoQ
Ownership
0.946%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$1,095,120
PutShares
216,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. ARDX ranks #88 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ARDX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,998,592 | 2,336,994 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,876,677 | 2,208,693 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,624,622 | 2,654,197 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $21,669,711 | 5,527,988 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,376,026 | 2,927,908 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,752,934 | 1,923,656 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $1,095,120 | 216,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $1,488,240 | 216,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $6,301,717 | 914,618 | Shares | Defined | 2025-03-18 | |
| 2024-06-30 | $1,600,560 | 216,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $13,390,668 | 1,807,108 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,635,200 | 224,000 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $3,513,073 | 481,243 | Shares | Defined | 2025-03-18 | |
| 2023-12-31 | $2,851,745 | 459,959 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,601,460 | 258,300 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $4,018,308 | 984,880 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $1,053,864 | 258,300 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $8,210,950 | 2,422,110 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $875,637 | 258,300 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $9,956,008 | 2,078,499 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $458,104 | 160,739 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $298,333 | 250,701 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $155,716 | 263,926 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $527,152 | 492,666 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $46,247 | 42,043 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,089,447 | 825,340 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $297,764 | 39,283 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $389,559 | 58,846 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $777,738 | 120,207 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $496,145 | 94,504 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $238,545 | 34,472 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $134,091 | 23,587 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||